These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31556252)

  • 1. Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross-infections.
    Milczewska J; Wołkowicz T; Zacharczuk K; Mierzejewska E; Kwiatkowska M; Walicka-Serzysko K; Sands D
    Pediatr Pulmonol; 2020 Jan; 55(1):161-168. PubMed ID: 31556252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.
    Denton M; Kerr K; Mooney L; Keer V; Rajgopal A; Brownlee K; Arundel P; Conway S
    Pediatr Pulmonol; 2002 Oct; 34(4):257-61. PubMed ID: 12205566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-infections with Pseudomonas aeruginosa in patients with cystic fibrosis attending the Warsaw Centre.
    Milczewska J; Wołkowicz T; Zacharczuk K; Kwiatkowska M
    Dev Period Med; 2015; 19(1):60-5. PubMed ID: 26003071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran.
    Movahedi Z; Pourakbari B; Mahmoudi S; Sabouni F; Ashtiani Haghi MT; Hosseinpour Sadeghi R; Mamishi S
    J Prev Med Hyg; 2013 Mar; 54(1):24-8. PubMed ID: 24397002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa Isolates From a Cohort of Mexican Children With Cystic Fibrosis Show Adaptation to a Chronic Phenotype.
    Rosales-Reyes R; Rodríguez-Alvarado M; Lezana-Fernández JL; Sánchez-Lozano JY; Gayosso-Vázquez C; Jarillo-Quijada MD; Toledano-Tableros JE; Arredondo-Mercado MJ; Alcántar-Curiel MD; Lincopan N; Vidal JE; Lascurain R; Valvano MA; Santos-Preciado JI
    Pediatr Infect Dis J; 2020 Oct; 39(10):899-906. PubMed ID: 32453200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
    Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
    Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
    BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis.
    Cios K; Cohen B; Quittell LM; Liu J; Larson EL
    Am J Infect Control; 2019 Jul; 47(7):750-754. PubMed ID: 30732978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.
    Jones AM; Dodd ME; Doherty CJ; Govan JR; Webb AK
    Thorax; 2002 Nov; 57(11):924-5. PubMed ID: 12403871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India.
    Agarwal G; Kapil A; Kabra SK; Chandra R; Das B; Diwedi SN
    Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
    Ferroni A; Guillemot D; Moumile K; Bernede C; Le Bourgeois M; Waernessyckle S; Descamps P; Sermet-Gaudelus I; Lenoir G; Berche P; Taddei F
    Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population.
    Middleton MA; Layeghifard M; Klingel M; Stanojevic S; Yau YCW; Zlosnik JEA; Coriati A; Ratjen FA; Tullis ED; Stephenson A; Wilcox P; Freitag A; Chilvers M; McKinney M; Lavoie A; Wang PW; Guttman DS; Waters VJ
    Ann Am Thorac Soc; 2018 Jul; 15(7):827-836. PubMed ID: 29911888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units.
    O'Carroll MR; Syrmis MW; Wainwright CE; Greer RM; Mitchell P; Coulter C; Sloots TP; Nissen MD; Bell SC
    Eur Respir J; 2004 Jul; 24(1):101-6. PubMed ID: 15293611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
    Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
    BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
    Taccetti G; Campana S; Festini F; Mascherini M; Döring G
    Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.